Sernova Corp. (TSE:SVA - Get Free Report) was up 5% during trading on Tuesday . The stock traded as high as C$0.21 and last traded at C$0.21. Approximately 48,100 shares changed hands during trading, a decline of 65% from the average daily volume of 137,715 shares. The stock had previously closed at C$0.20.
Sernova Stock Performance
The company has a current ratio of 0.32, a quick ratio of 18.11 and a debt-to-equity ratio of -4.40. The firm has a market capitalization of C$67.30 million, a price-to-earnings ratio of -1.93 and a beta of 1.35. The stock's 50 day moving average price is C$0.19 and its two-hundred day moving average price is C$0.21.
About Sernova
(
Get Free Report)
Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues.
Further Reading
Before you consider Sernova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sernova wasn't on the list.
While Sernova currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.